MR. GEORGE FREDERICK GEILS M.D. NPI 1093773657

NPI Information

  • NPI: 1093773657
  • Provider Name: MR. GEORGE FREDERICK GEILS, M.D.
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 2085 HENRY TECKLENBURG DR
    CHARLESTON, SC
    ZIP 29414
  • Phone: (843) 577-6957

Map and Directions

Get Directions

NPI Details

MR. George Frederick Geils, M.D. is a hematology and oncology internal medicine in Charleston, SC with 35 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. MR. George Frederick Geils, M.D. NPI is 1093773657. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:1990

The provider's business location address is:

2085 HENRY TECKLENBURG DR
CHARLESTON, SC
ZIP 29414-710
Phone: (843) 577-6957
Fax: (843) 577-6523

The NPI 1093773657 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
  • Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS:Q0138)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, fosaprepitant, 1 mg (HCPCS:J1453)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, ferric derisomaltose, 10 mg (HCPCS:J1437)
  • Injection, rituximab-abbs, biosimilar, (truxima), 10 mg (HCPCS:Q5115)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
  • Lactate dehydrogenase (enzyme) level (HCPCS:83615)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, zoledronic acid, 1 mg (HCPCS:J3489)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a (HCPCS:G9678)
  • Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Iron binding capacity (HCPCS:83550)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • Iron level (HCPCS:83540)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Ct scan of chest with contrast (HCPCS:71260)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
  • Injection, midazolam hydrochloride, per 1 mg (HCPCS:J2250)
  • Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
  • Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Psa (prostate specific antigen) measurement, total (HCPCS:84153)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Red blood count, automated test (HCPCS:85045)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • Stool analysis for blood to screen for colon tumors (HCPCS:82270)
  • Ct scan of chest without contrast (HCPCS:71250)
  • Urinalysis, manual test (HCPCS:81002)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • Biopsy and aspiration of bone marrow sample for diagnosis (HCPCS:38222)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Injection, meperidine hydrochloride, per 100 mg (HCPCS:J2175)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Hospital discharge day management, more than 30 minutes (HCPCS:99239)
  • Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
  • Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
  • Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or (HCPCS:G2212)

The enumeration date for this NPI number is 5/3/2006 and was last updated on 1/4/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0003XInternal MedicineHematology & Oncology18925SOUTH CAROLINAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1P00357883OTHERSOUTH CAROLINARAILROAD MEDICARE
2T25700MEDICAIDSOUTH CAROLINA

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 3/30/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.